» Articles » PMID: 28395747

Generation of Induced Pluripotent Stem Cells (iPSCs) from a Hypertrophic Cardiomyopathy Patient with the Pathogenic Variant P.Val698Ala in Beta-myosin Heavy Chain (MYH7) Gene

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2017 Apr 12
PMID 28395747
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) isolated from the whole blood of a 43-year-old male with hypertrophic cardiomyopathy (HCM) who carries the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7). Patient-derived PBMCs were reprogrammed using non-integrative episomal vectors containing reprogramming factors OCT4, SOX2, LIN28, KLF4 and L-MYC. iPSCs were shown to express pluripotent markers, have trilineage differentiation potential, carry the pathogenic MYH7 variant p.Val698Ala, have a normal karyotype and no longer carry the episomal reprogramming vector. This line is useful for studying the link between variants in MYH7 and the pathogenesis of HCM.

Citing Articles

Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.

Ribeiro M, Jager J, Furtado M, Carvalho T, Cabral J, Brito D Hum Cell. 2024; 37(4):1205-1214.

PMID: 38762696 PMC: 11194200. DOI: 10.1007/s13577-024-01073-y.


Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target.

Dattani A, Singh A, McCann G, Gulsin G J Cardiovasc Dev Dis. 2024; 11(1).

PMID: 38248882 PMC: 10817027. DOI: 10.3390/jcdd11010012.


MYH7 in cardiomyopathy and skeletal muscle myopathy.

Gao Y, Peng L, Zhao C Mol Cell Biochem. 2023; 479(2):393-417.

PMID: 37079208 DOI: 10.1007/s11010-023-04735-x.


Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.

Li J, Feng X, Wei X Stem Cell Res Ther. 2022; 13(1):232.

PMID: 35659761 PMC: 9166443. DOI: 10.1186/s13287-022-02905-0.


Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.

Li Y, Lang S, Akin I, Zhou X, El-Battrawy I J Am Heart Assoc. 2022; 11(7):e024410.

PMID: 35322667 PMC: 9075459. DOI: 10.1161/JAHA.121.024410.